Zions Bancorporation N.A. Raises Stock Holdings in Zoetis Inc. (NYSE:ZTS)

Zions Bancorporation N.A. increased its stake in shares of Zoetis Inc. (NYSE:ZTS) by 11.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,036 shares of the company’s stock after purchasing an additional 2,219 shares during the quarter. Zions Bancorporation N.A.’s holdings in Zoetis were worth $4,110,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Avantax Advisory Services Inc. grew its stake in Zoetis by 6.2% in the 1st quarter. Avantax Advisory Services Inc. now owns 10,223 shares of the company’s stock worth $1,730,000 after acquiring an additional 596 shares during the period. HBK Sorce Advisory LLC grew its position in shares of Zoetis by 1.8% in the first quarter. HBK Sorce Advisory LLC now owns 6,030 shares of the company’s stock valued at $1,020,000 after purchasing an additional 104 shares during the period. Orion Portfolio Solutions LLC increased its stake in Zoetis by 10.8% in the first quarter. Orion Portfolio Solutions LLC now owns 66,099 shares of the company’s stock valued at $11,185,000 after purchasing an additional 6,441 shares during the last quarter. Dorsey & Whitney Trust CO LLC lifted its position in Zoetis by 16.0% during the first quarter. Dorsey & Whitney Trust CO LLC now owns 4,643 shares of the company’s stock worth $786,000 after buying an additional 641 shares during the period. Finally, Great Lakes Retirement Inc. boosted its stake in Zoetis by 4.2% in the 1st quarter. Great Lakes Retirement Inc. now owns 6,794 shares of the company’s stock worth $1,150,000 after buying an additional 271 shares during the last quarter. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Piper Sandler increased their price objective on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, August 14th. JPMorgan Chase & Co. increased their price target on shares of Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Argus raised shares of Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. Stifel Nicolaus increased their target price on Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a research report on Wednesday, September 18th. Finally, BTIG Research lifted their target price on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a report on Monday, August 12th. Ten equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $221.44.

Zoetis Trading Up 1.9 %

NYSE:ZTS opened at $177.28 on Thursday. The business’s 50-day moving average is $187.61 and its two-hundred day moving average is $180.02. The firm has a market capitalization of $79.98 billion, a PE ratio of 33.32, a price-to-earnings-growth ratio of 2.67 and a beta of 0.90. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $201.92. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27.

Zoetis (NYSE:ZTS) last announced its earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, beating the consensus estimate of $1.46 by $0.12. The business had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The company’s revenue was up 11.6% on a year-over-year basis. During the same period last year, the business posted $1.36 EPS. Research analysts predict that Zoetis Inc. will post 5.9 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st will be paid a $0.432 dividend. The ex-dividend date is Thursday, October 31st. This represents a $1.73 annualized dividend and a dividend yield of 0.97%. Zoetis’s dividend payout ratio (DPR) is presently 32.52%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.